Gella, Amberield M.
HRN: 23-48-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
CEFTRIAXONE 1G (VIAL)
08/07/2023
08/14/2023
IV
2g
OD
T/C Acute AP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes